http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5066786-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_deff0ab87e07d714dcf3d03223972069 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-565 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-565 |
| filingDate | 1988-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1991-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc5341b441890fb530ee21373113a529 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4acf7e3353f0253aed10975bbb43f5c7 |
| publicationDate | 1991-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-5066786-A |
| titleOfInvention | Method for the purification of interferon |
| abstract | A method is described for the purification of crude human interferon from solutions containing it, which comprises: a) the complete adsorption of the crude interferon in a column of siliceous material which has previously been disinfected with an aqueous solution of formaldehyde; b) the washing of the column with non-pyrogenic, sterile, deionised water; c) the removal of the extraneous residual proteins by the elution of the column successively with a 1.4 M aqueous solution of NaCl, with non-pyrogenic, sterile, deionised water, and with an aqueous solution of a solvent having hydrophobic and acidic properties at a molar concentration of 0.001 M to 0.003 M; d) the elution of the interferon from the column with an aqueous solution of the same solvent as that used in step c) at a molar concentration of from 0.01 to 0.03 M and finally, e) the recovery and lyophilisation of the eluted fraction and/or fractions containing the purified interferon. The method enables interferon to be obtained, the purity of which, measured as its specific activity, is at least 1000 times greater than that of the crude interferon, with a yield greater than 85%. The interferon thus purified is particularly useful for treatment in man. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007123697-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8232371-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007093649-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006008447-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2473696-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7662369-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8097702-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8119603-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7780960-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7901670-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5710027-A |
| priorityDate | 1987-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 38.